Hybio Pharmaceutical Co., Ltd.

Hybio Pharmaceutical Co., Ltd.verified

300199.SZ

Price:

$18.75

Market Cap:

$16.56B

Hybio Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of therapeutic peptides API and polypeptide drugs in China and internationally. The company provides liraglutide, semaglutide and exenatide for diabetes; terlipressin, desmopressin and linaclotide for digestive tract and metabolic system; ganirelix, cetrorelix and atosiban for obstetrics and gynecology, etc; customized peptides; working standards for the peptide APIs and related impurities, to facilitate your project in an all-round way; CRO services; and platform for CDMO services, which includes peptide API synthesis and purification process development, finish dosage form development, reference s...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2011-04-07

Stock Exchange

SHZ

Ticker

300199.SZ

The PE Ratio as of December 2025 (TTM) for Hybio Pharmaceutical Co., Ltd. (300199.SZ) is -234.37

According to Hybio Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -234.37. This represents a change of -7726.34% compared to the average of 3.07 of the last 4 quarters.

Hybio Pharmaceutical Co., Ltd. (300199.SZ) Historical PE Ratio (quarterly & annually)

How has 300199.SZ PE Ratio performed in the past?

The mean historical PE Ratio of Hybio Pharmaceutical Co., Ltd. over the last ten years is 36.58. The current -234.37 PE Ratio has changed -64169.97% with respect to the historical average. Over the past ten years (40 quarters), 300199.SZ's PE Ratio was at its highest in in the June 2024 quarter at 645.94. The PE Ratio was at its lowest in in the March 2024 quarter at -193.22.

Quarterly (TTM)
Annual

Average

36.58

Median

-7.71

Minimum

-64.45

Maximum

361.52

Hybio Pharmaceutical Co., Ltd. (300199.SZ) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Hybio Pharmaceutical Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 178.13%

Maximum Annual PE Ratio = 361.52

Minimum Annual Increase = -3851.07%

Minimum Annual PE Ratio = -64.45

Quarterly (TTM)
Annual
YearPE RatioChange
2024-64.45178.13%
2023-23.17-44.70%
2022-41.90-111.59%
2021361.52-3851.07%
2020-9.6466.46%
2019-5.79-75.73%
2018-23.86-151.68%
201746.17-15.27%
201654.48-24.79%
201572.441.95%

Hybio Pharmaceutical Co., Ltd. (300199.SZ) Average PE Ratio

How has 300199.SZ PE Ratio performed in the past?

The current PE Ratio of Hybio Pharmaceutical Co., Ltd. (300199.SZ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-43.18

5-year avg

44.47

10-year avg

36.58

Hybio Pharmaceutical Co., Ltd. (300199.SZ) PE Ratio vs. Peers

How is 300199.SZ’s PE Ratio compared to its peers?

Hybio Pharmaceutical Co., Ltd.’s PE Ratio is less than Shenzhen Kangtai Biological Products Co., Ltd. (-169.74), less than Fujian Cosunter Pharmaceutical Co., Ltd. (-72.32), less than China Resources Double-Crane Pharmaceutical Co.,Ltd. (12.20), less than Walvax Biotechnology Co., Ltd. (367.97), less than Zhejiang Jiuzhou Pharmaceutical Co., Ltd (22.27), less than Beijing Aosaikang Pharmaceutical Co., Ltd. (61.60), less than Guangdong Zhongsheng Pharmaceutical Co., Ltd. (-89.61), less than Apeloa Pharmaceutical Co.,Ltd (21.43), less than Joincare Pharmaceutical Group Industry Co.,Ltd. (16.71), less than Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (41.10),

Build a custom stock screener for Hybio Pharmaceutical Co., Ltd. (300199.SZ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hybio Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hybio Pharmaceutical Co., Ltd. (300199.SZ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hybio Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Hybio Pharmaceutical Co., Ltd.'s PE Ratio?

How is the PE Ratio calculated for Hybio Pharmaceutical Co., Ltd. (300199.SZ)?

What is the highest PE Ratio for Hybio Pharmaceutical Co., Ltd. (300199.SZ)?

What is the 3-year average PE Ratio for Hybio Pharmaceutical Co., Ltd. (300199.SZ)?

What is the 5-year average PE Ratio for Hybio Pharmaceutical Co., Ltd. (300199.SZ)?

How does the current PE Ratio for Hybio Pharmaceutical Co., Ltd. (300199.SZ) compare to its historical average?